November 17, 2016
Tax Partner John Mezzanotte spoke with BioSpace about international tax considerations for pharma companies.
Biospace
By Renee Morad
Excerpt:
It comes as no surprise that many pharma companies are reported as paying the lowest overall tax rates, particularly since the industry is modeled in a unique way that is especially conducive to allowing companies to have operations in different parts of the world, says John Mezzanotte, partner-in-charge of the Greenwich, Conn. office of public accounting and advisory services firm Marcum LLP. “Moves to operate in various countries can be driven and motivated by low tax jurisdictions,” he explains.
